Story timeline

1 updates

Deal Discussions

AstraZeneca is in preliminary talks with Bristol Myers Squibb regarding a $400 billion merger that would create the world's fourth-largest pharmaceutical company by market value.

updates

3 August 2026
AstraZeneca in Talks with Bristol Myers Squibb Over $400B Deal
AstraZeneca is in preliminary talks with Bristol Myers Squibb regarding a $400 billion merger that would create the world's fourth-largest pharmaceutical company by market value.